Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Events

Events

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Entertainment
  • Events
  • Gaming
  • General
  • News
  • Tech

E3 2023 Takes Major Hit As Big 3 Pull Out: Microsoft, Sony, Nintendo Not Attending Electronic Entertainment Expo This Year

By Franca Quarneti
Yesterday, 4:15 PM
E3, the largest video game conference and trade show in the world, is facing a setback for its upcoming 2023 edition: Microsoft (NASDAQ: MSFT)'s Xbox, Sony (NYSE: SONY) and Ni

MSFT

Read More
3 minute read
  • Cannabis
  • Events
  • Markets
  • News
  • Psychedelics

Women’s Footprint In Psychedelics Is Undeniable, Benzinga’s Psychedelics Advisory Council’s Six New Trailblazers

By Lara Goldstein
January 30, 1:50 PM
In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council.

KONEF

Read More
1 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News
  • Trading Ideas

Aridis Pharmaceuticals Currently Presenting Webinar; ‘New Approaches To Treating Infections In Cystic Fibrosis Patients AR-501 Phase 2 Trial Update’; Shares Spike Lower

By Benzinga Newsdesk
January 24, 12:19 PM
https://redchip.zoom.us/webinar/register/WN_WB4K1ES0S1aJzl5ucesN5A

ARDS

Read More
4 minute read
  • Events
  • Interview
  • News
  • Tech
  • Top Stories

Davos 2023: Hedera Exec Spent Years On Capitol Hill, Now She’s Shaping Blockchain Policy

By Renato Capelj
January 24, 11:26 AM
The World Economic Forum (WEF), which recently took place in Davos, Switzerland, featured some note-worthy attendees, including Ursula von der Leyen, the President of the European Commission; Olena Zelenska, the First Lady of Ukraine; actor Idris Elba and many others.

$HBAR

Read More
1 minute read
  • Events
  • News

Genetic Technologies Announced Monday A Poster Presentation: Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk ASCOGI

By Charles Gross
January 24, 5:47 AM
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce a poster presentation by Dr Erika Speath at the prestigious American Society of Clinical Oncology Gastroenterology Cancer Symposium in San Francisco last weekend.

GENE

Read More
1 minute read
  • Biotech
  • Events
  • General
  • News

Ra Medical Systems Announces The Presentation Of Clinical Data At The European Heart Rhythm Association Congress

By Benzinga Newsdesk
January 23, 7:51 AM
Ra Medical Systems, Inc. (NYSE:RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been

RMED

Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

Salarius Pharmaceuticals To Present SP-3164 Targeted Protein Degrader Preclinical Data At The Inaugural Molecular Glue Drug Development Summit

By Benzinga Newsdesk
January 19, 9:44 AM
Dr. Aundrietta Duncan to discuss mechanism of action and SP-3164 activity in cancer models Company planning to submit an Investigational New Drug application to the U.S. Food and Drug Administration and begin a Phase 1

SLRX

Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented At 2023 APSARD Conference

By Benzinga Newsdesk
January 19, 9:42 AM
ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Dr. Keith McBurnett, Professor of

ABVC

Read More
1 minute read
  • Events
  • News
  • Rumors
  • Trading Ideas

Watching Provention Bio; Shares Move Lower As Co Showcases Webinar Titled ‘Tzield: Learn More About A Newly Approved Therapy’

By Benzinga Newsdesk
January 18, 1:56 PM
https://members.amcp.org/AMCP2019/Events/Event_Display.aspx?EventKey=GTW_230118&WebsiteKey=2bfc55cc-0861-4d8b-91d1-9a8c0f748666

PRVB

Read More
4 minute read
  • Cannabis
  • Contracts
  • Events
  • Financing
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Retail Sales
  • Rumors
  • Small Cap

Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood’s Latest Moves And More

By Lara Goldstein
January 17, 7:38 PM
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January.

ATAI

Posts navigation

1 2 … 158 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service